If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Plc Regulatory News (HAYD)

Share Price Information for Haydale Plc (HAYD)

Share Price is delayed by 15 minutes
Get Live Data
0.295    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.01 (3.448%)
Market Cap: £22.94m
HAYD Live PriceLast checked at - London Stock Exchange

Intraday Haydale Plc Share Chart

Director/PDMR Shareholding

1 Mar 2022 17:26

RNS Number : 2782D
Haydale Graphene Industries PLC
01 March 2022
 

For immediate release

1 March 2022

 

Haydale Graphene Industries plc

 

('Haydale' or the 'Group')

 

Director/PDMR Shareholding

 

Haydale, (AIM: HAYD), the global advanced materials group, has today been informed that Mark Chapman, Chief Financial Officer of the Company has transferred 285,714 ordinary shares of 2p each in the Company ("Ordinary Shares") from his personal holding into his ISA. Following this transaction Mr Chapman's interest in Company remains unchanged.

 

For further information:

 

Haydale Graphene Industries plc

Keith Broadbent, Chief Executive Officer

Mark Chapman, Chief Financial Officer

Tel: +44 (0) 1269 842 946

 

finnCap (Nominated Adviser & Broker)

Julian Blunt/Edward Whiley, Corporate Finance

Andrew Burdis, ECM

Tel: +44 (0) 20 7220 0500 

 

 

 

 

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

Jonathan Mark Chapman

2

Reason for notification

 

 

a.

Position/Status

Chief Financial Officer of Haydale Graphene Industries plc

b.

Initial notification/

Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Haydale Graphene Industries Plc

b.

LEI

213800KNULBQFF25IE72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrumentIdentification Code

Ordinary Shares of 2p each

 

GB00BKWQ1135

b.

Nature of the transaction

Transfer of Shares to ISA via a sale and purchase.

c.

Price(s) and volume(s)

Price(s)

Volume(s)

 0.0440p Sale

 285,714

 0.0441p Purchase

285,714

d.

Aggregated information

 

- Aggregated Volume

 

- Price

As above

 

e.

Date of the transaction

1 March 2022

f.

Place of the transaction

AIMX - LONDON STOCK EXCHANGE - AIM MTF.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBRGDXUDGDGDB
Date   Source Headline
3rd Dec 20245:38 pmRNSHolding(s) in Company
2nd Dec 20247:00 amRNSFinal Results
22nd Nov 20245:27 pmRNSHolding(s) in Company
21st Nov 202411:48 amRNSDirectorate Change
15th Nov 20242:06 pmRNSHolding(s) in Company
14th Nov 20242:45 pmRNSHolding(s) in Company
13th Nov 20242:10 pmRNSResult of General Meeting and TVR
28th Oct 20245:12 pmRNSResult of Retail Offer
28th Oct 20247:00 amRNSResult of Fundraising
25th Oct 20242:20 pmRNSRetail Offer
25th Oct 20242:15 pmRNSProposed Fundraise to raise up to £3.5 million
9th Jul 20247:00 amRNSNew Agreement Worth US$4.0 million
20th May 20247:00 amRNSTrading Update
2nd May 20247:00 amRNSGrant of Share Options and PDMR Dealing
12th Mar 20247:00 amRNSInterim Results
26th Jan 20247:00 amRNSGrant of Options & Surrender of Existing Options
22nd Jan 20247:00 amRNSHaydale selected for Innovate UK Scaleup Programme
7th Dec 202311:36 amRNSResult of AGM
7th Dec 202311:34 amRNSDirectorate Change
6th Dec 20237:00 amRNSHaydale awarded SMART funding
16th Nov 20232:31 pmRNSHolding(s) in Company
13th Nov 20237:00 amRNSPosting of Annual Report & Notice of AGM
1st Nov 20237:00 amRNSTotal Voting Rights
26th Oct 20237:00 amRNSFinal Results
9th Oct 20238:23 amRNSHolding(s) in Company
5th Oct 20231:43 pmRNSDirector/PDMR Shareholding & Total Voting Rights
4th Oct 20234:46 pmRNSHolding(s) in Company
3rd Oct 20233:48 pmRNSResult of General Meeting
2nd Oct 20237:00 amRNSTotal Voting Rights
22nd Sep 20234:30 pmRNSResult of Retail Offer and Total Voting Rights
15th Sep 20236:12 pmRNSResult of Fundraising
15th Sep 20234:00 pmRNSLaunch of Retail Offer
15th Sep 20233:00 pmRNSProposed Placing, Subscription & Retail Offer
15th Sep 20237:00 amRNSWarrant Expiry, Block Admission Cancellation & TVR
22nd Aug 20237:00 amRNSCollaboration with PETRONAS
4th Aug 20231:02 pmRNSHolding(s) in Company
2nd Aug 20237:00 amRNSDirectorate Change
24th Jul 20237:00 amRNSContract Award
13th Jul 20237:00 amRNSHaydale Delivers LPHW Prototype for Cadent
21st Jun 20237:00 amRNSTrading Update
5th Jun 20237:00 amRNSDirectorate Change
24th May 20237:00 amRNSHaydale to Contribute to the Development of FCHEVs
3rd May 20237:00 amRNSSMART Innovation to Accelerate Graphene Products
26th Apr 20233:06 pmRNSGrant of Share Options
12th Apr 20237:00 amRNSHaydale and Saint-Gobain Collaborate on hBN
16th Mar 20237:00 amRNSHaydale and City Energy Develop UFH with Plumbase
14th Mar 20238:15 amRNSBlock listing Interim Review
10th Mar 202311:05 amRNSSecond Price Monitoring Extn
10th Mar 202311:00 amRNSPrice Monitoring Extension
10th Mar 20237:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.